Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark R Cookson

Showing results (141-150 of 320) with videos related to

Pageof 32
Sort By:
Journal of Cellular and Molecular Medicine|August 23, 2018
Reduction of PINK1 or DJ-1 impair mitochondrial motility in neurites and alter ER-mitochondria contactsCristina Parrado-Fernández, Bernadette Schneider, Maria Ankarcrona, et al.
The Biochemical Journal|May 23, 2012
The G2385R variant of leucine-rich repeat kinase 2 associated with Parkinson's disease is a partial loss-of-function mutationIakov N Rudenko, Alice Kaganovich, David N Hauser, et al.
Science (New York, N.Y.)|April 16, 2026
Sex effects on gene expression across the human cerebral cortex at cell type resolutionAlex R DeCasien, Pavan Auluck, Siyuan Liu, et al.
Cellular and Molecular Life Sciences : CMLS|November 25, 2019
Molecular mechanism of olesoxime-mediated neuroprotection through targeting α-synuclein interaction with mitochondrial VDACAmandine Rovini, Philip A Gurnev, Alexandra Beilina, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 6, 2009
Membrane-associated farnesylated UCH-L1 promotes alpha-synuclein neurotoxicity and is a therapeutic target for Parkinson's diseaseZhihua Liu, Robin K Meray, Tom N Grammatopoulos, et al.
The American Journal of Pathology|July 25, 2009
Metabolic activity determines efficacy of macroautophagic clearance of pathological oligomeric alpha-synucleinWai Haung Yu, Beatriz Dorado, Helen Yvette Figueroa, et al.
Cellular and Molecular Life Sciences : CMLS|January 11, 2020
Correction to: Molecular mechanism of olesoxime-mediated neuroprotection through targeting α-synuclein interaction with mitochondrial VDACAmandine Rovini, Philip A Gurnev, Alexandra Beilina, et al.
Biorxiv : the Preprint Server for Biology|October 1, 2025
A xeno-free protocol for rapid differentiation of human iPSC-derived microglia from the KOLF2.1J reference lineNélio A J Oliveira, Katherine R Lewkowicz, Patricia A Clow, et al.
Plos Biology|February 4, 2010
PINK1 is selectively stabilized on impaired mitochondria to activate ParkinDerek P Narendra, Seok Min Jin, Atsushi Tanaka, et al.
Neuroscience Letters|January 17, 2009
Post-transcriptional regulation of mRNA associated with DJ-1 in sporadic Parkinson diseaseJeff Blackinton, Ravindran Kumaran, Marcel P van der Brug, et al.
Pageof 32

Showing results (141-150 of 320) with videos related to

Sort By:
Pageof 32
Journal of Cellular and Molecular Medicine|August 23, 2018
Reduction of PINK1 or DJ-1 impair mitochondrial motility in neurites and alter ER-mitochondria contactsCristina Parrado-Fernández, Bernadette Schneider, Maria Ankarcrona, et al.
The Biochemical Journal|May 23, 2012
The G2385R variant of leucine-rich repeat kinase 2 associated with Parkinson's disease is a partial loss-of-function mutationIakov N Rudenko, Alice Kaganovich, David N Hauser, et al.
Science (New York, N.Y.)|April 16, 2026
Sex effects on gene expression across the human cerebral cortex at cell type resolutionAlex R DeCasien, Pavan Auluck, Siyuan Liu, et al.
Cellular and Molecular Life Sciences : CMLS|November 25, 2019
Molecular mechanism of olesoxime-mediated neuroprotection through targeting α-synuclein interaction with mitochondrial VDACAmandine Rovini, Philip A Gurnev, Alexandra Beilina, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 6, 2009
Membrane-associated farnesylated UCH-L1 promotes alpha-synuclein neurotoxicity and is a therapeutic target for Parkinson's diseaseZhihua Liu, Robin K Meray, Tom N Grammatopoulos, et al.
The American Journal of Pathology|July 25, 2009
Metabolic activity determines efficacy of macroautophagic clearance of pathological oligomeric alpha-synucleinWai Haung Yu, Beatriz Dorado, Helen Yvette Figueroa, et al.
Cellular and Molecular Life Sciences : CMLS|January 11, 2020
Correction to: Molecular mechanism of olesoxime-mediated neuroprotection through targeting α-synuclein interaction with mitochondrial VDACAmandine Rovini, Philip A Gurnev, Alexandra Beilina, et al.
Biorxiv : the Preprint Server for Biology|October 1, 2025
A xeno-free protocol for rapid differentiation of human iPSC-derived microglia from the KOLF2.1J reference lineNélio A J Oliveira, Katherine R Lewkowicz, Patricia A Clow, et al.
Plos Biology|February 4, 2010
PINK1 is selectively stabilized on impaired mitochondria to activate ParkinDerek P Narendra, Seok Min Jin, Atsushi Tanaka, et al.
Neuroscience Letters|January 17, 2009
Post-transcriptional regulation of mRNA associated with DJ-1 in sporadic Parkinson diseaseJeff Blackinton, Ravindran Kumaran, Marcel P van der Brug, et al.
Pageof 32